Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (57)

« Back to Publications

Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axis.

Beernaert B. et al, (2026), Sci Adv, 12

TMEM33 deletion potentiates anti-tumor CD8+ T cell immunity.

Jackson MT. et al, (2026)

Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.

Phillips R. et al, (2026), Br J Cancer, 134, 289 - 294

Single-cell proteomics sheds light on neutrophil diversity in glioblastoma.

Skolariki A. and Parkes EE., (2025), Nat Rev Immunol, 25

IGF-1 regulates cancer cell immune evasion in prostate cancer.

Nandakumar AM. et al, (2025), Sci Rep, 15

Replication-Competent, Tumor-Specific Immuno-Gene Vectors Allow for Exchange of Transgenes and Lead to Viral Persistence Following IV Administration.

Rosen LS. et al, (2025), J Immunother Precis Oncol, 8, 263 - 275

Interactions between cancer-associated fibroblasts and the extracellular matrix in oesophageal cancer.

Vadibeler S. et al, (2025), Matrix Biol, 139, 49 - 60

Nanotechnology for immuno-oncology.

Grippin AJ. et al, (2025), Nat Cancer, 6, 1311 - 1325

CINs of the cytoplasm: dissecting dsRNA signaling in chromosomal instability.

Skolariki A. et al, (2025), Mol Oncol, 19, 1561 - 1564

Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axis.

Beernaert B. et al, (2025)

Recurrent ERBB2 alterations are associated with esophageal adenocarcinoma brain metastases.

Lawson NM. et al, (2025)

Open-label, phase Ia study of STING agonist BI 1703880 plus ezabenlimab for patients with advanced solid tumors.

Harrington K. et al, (2025), Future Oncol, 21, 195 - 200

Redefining PD1 as a guardian of stem-like T cells.

Jackson M. and Parkes EE., (2025), Nat Rev Immunol, 25

IGFs regulate cancer cell immune evasion in prostate cancer

Nandakumar AM. et al, (2024)

Validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries: a retrospective, comparative analysis.

Jackson A. et al, (2024), Lancet Oncol, 25, 1476 - 1486

Load More